AcouSort is a Swedish life science technology company commercialising acoustophoresis, a method using sound waves for automated sample preparation. This gentle, label-free technology separates, washes, and concentrates cells and other particles, ensuring high viability and sample integrity. The company’s business model is twofold: providing OEM modules for integration into third-party diagnostic and cell therapy systems, and selling proprietary benchtop instruments for research. By automating complex preparation steps, AcouSort’s technology is vital for advancing point-of-care diagnostics and cell-based research. The company is publicly listed on the Nasdaq First North Growth Market.